SOX2 and glioma: In addition, STAT3 binding to the Notch1 promoter inhibits this signaling pathway and may impede the maintenance of glioma stem-like cells while reducing the expression of glioma stem cell markers CD133, SOX2, and nestin [98] (Figure 1).